In breast cancer, different subtypes of tumor samples, such as estrogen receptor positive and negative (ER+ and ER–), are characterized by distinct molecular mechanisms, suggesting possible differences in the post-transcriptional regulation between the subtype tumors. Here, ESR1 is linked to breast cancer.